Compounds > sparfloxacin
Page last updated: 2024-08-24

sparfloxacin and Infection, Mycobacterium avium-intracellulare

sparfloxacin has been researched along with Infection, Mycobacterium avium-intracellulare in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dekio, S; Hidaka, T; Kawahara, S; Saito, H; Sato, K; Tomioka, H1
Bermudez, LE; Inderlied, CB; Young, LS1
Düzgüneş, N; Flasher, D; Gangadharam, PR; Luna-Herrera, J; Reddy, MV1
Barbeau, P; Lapeyre, C; Leng, B; Maugein, J; Pellegrin, I; Pellegrin, JL1
Bollet, C; de Lamballerie, X; de Micco, P; Gevaudan, MJ; Mallet, MN; Sambuc, R1
Hadley, WK; Nassos, PS; Sanders, CA; Yajko, DM1

Other Studies

6 other study(ies) available for sparfloxacin and Infection, Mycobacterium avium-intracellulare

ArticleYear
Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.
    Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1995, Volume: 76, Issue:1

    Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rifamycins; Streptomycin

1995
Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:5

    Topics: Anti-Infective Agents; Azithromycin; Bacterial Adhesion; Fluoroquinolones; Humans; Intestinal Mucosa; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones; Rifabutin; Tumor Cells, Cultured

1994
Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:11

    Topics: Animals; Anti-Infective Agents; Cell Line; Cell Survival; Fluoroquinolones; Humans; Indicators and Reagents; Liposomes; Macrophages; Mice; Mice, Inbred Strains; Mycobacterium avium-intracellulare Infection; Quinolones

1996
Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones; Rifabutin

1996
[Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Pathologie-biologie, 1992, Volume: 40, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Mycobacterium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Opportunistic Infections; Quinolones; Rifabutin; Rifamycins

1992
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Ciprofloxacin; Drug Synergism; Ethambutol; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin

1990